Kevin Scott Emerick, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Head and Neck Neoplasms | 40 | 2023 | 2894 | 4.080 |
Why?
|
Carcinoma, Squamous Cell | 26 | 2023 | 4024 | 2.690 |
Why?
|
Skin Neoplasms | 24 | 2024 | 5821 | 2.530 |
Why?
|
Surgical Flaps | 20 | 2021 | 1671 | 2.250 |
Why?
|
Sentinel Lymph Node Biopsy | 6 | 2021 | 732 | 1.540 |
Why?
|
Free Tissue Flaps | 9 | 2023 | 331 | 1.200 |
Why?
|
Carcinoma, Merkel Cell | 7 | 2024 | 328 | 1.180 |
Why?
|
Laryngectomy | 7 | 2020 | 243 | 1.080 |
Why?
|
Otolaryngology | 6 | 2019 | 693 | 0.870 |
Why?
|
Lymphatic Metastasis | 7 | 2021 | 2915 | 0.780 |
Why?
|
Parotid Gland | 3 | 2023 | 175 | 0.780 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 2 | 2018 | 1068 | 0.770 |
Why?
|
Ranula | 2 | 2018 | 10 | 0.720 |
Why?
|
Laryngeal Neoplasms | 7 | 2018 | 514 | 0.720 |
Why?
|
Larynx, Artificial | 5 | 2014 | 69 | 0.680 |
Why?
|
Lymphoma, B-Cell, Marginal Zone | 2 | 2010 | 178 | 0.630 |
Why?
|
Neoplasm Staging | 16 | 2023 | 11120 | 0.630 |
Why?
|
Facial Nerve Diseases | 2 | 2016 | 49 | 0.600 |
Why?
|
Parotid Neoplasms | 3 | 2019 | 157 | 0.530 |
Why?
|
Smiling | 1 | 2016 | 72 | 0.510 |
Why?
|
Oropharyngeal Neoplasms | 5 | 2022 | 491 | 0.500 |
Why?
|
Neuralgia | 1 | 2021 | 615 | 0.480 |
Why?
|
Melanoma | 5 | 2023 | 5709 | 0.480 |
Why?
|
Ear Auricle | 1 | 2014 | 31 | 0.470 |
Why?
|
Carcinoma, Basal Cell | 2 | 2022 | 560 | 0.450 |
Why?
|
Carcinoma, Mucoepidermoid | 2 | 2019 | 89 | 0.430 |
Why?
|
Facial Neoplasms | 1 | 2014 | 125 | 0.430 |
Why?
|
Lymphoma, B-Cell | 2 | 2010 | 940 | 0.420 |
Why?
|
Drainage | 2 | 2016 | 1157 | 0.420 |
Why?
|
Facial Paralysis | 1 | 2016 | 346 | 0.400 |
Why?
|
Retrospective Studies | 44 | 2024 | 80647 | 0.390 |
Why?
|
Skull Base | 1 | 2014 | 292 | 0.380 |
Why?
|
Clavicle | 6 | 2018 | 224 | 0.380 |
Why?
|
Arteries | 2 | 2015 | 1123 | 0.380 |
Why?
|
Scalp | 1 | 2014 | 389 | 0.370 |
Why?
|
Lymph Nodes | 4 | 2021 | 3465 | 0.370 |
Why?
|
Neoplasm Invasiveness | 7 | 2021 | 3597 | 0.360 |
Why?
|
Retropharyngeal Abscess | 1 | 2010 | 21 | 0.350 |
Why?
|
Education, Medical, Graduate | 3 | 2018 | 2373 | 0.320 |
Why?
|
Mouth Neoplasms | 3 | 2021 | 596 | 0.320 |
Why?
|
Papillomavirus Infections | 4 | 2022 | 1613 | 0.310 |
Why?
|
Forearm | 3 | 2023 | 427 | 0.310 |
Why?
|
Oncolytic Viruses | 2 | 2023 | 344 | 0.310 |
Why?
|
Humans | 101 | 2024 | 761596 | 0.300 |
Why?
|
Jaw Diseases | 1 | 2008 | 92 | 0.300 |
Why?
|
Nose Diseases | 1 | 2008 | 79 | 0.300 |
Why?
|
Oral Surgical Procedures | 2 | 2021 | 166 | 0.300 |
Why?
|
Surgical Wound Infection | 5 | 2021 | 1529 | 0.290 |
Why?
|
Range of Motion, Articular | 1 | 2014 | 1588 | 0.290 |
Why?
|
Carcinoma, Adenoid Cystic | 2 | 2022 | 262 | 0.290 |
Why?
|
Facial Bones | 1 | 2008 | 208 | 0.280 |
Why?
|
Tissue Transplantation | 1 | 2007 | 128 | 0.280 |
Why?
|
Otorhinolaryngologic Surgical Procedures | 3 | 2016 | 324 | 0.270 |
Why?
|
Adenoids | 1 | 2006 | 35 | 0.260 |
Why?
|
Cystadenocarcinoma | 1 | 2005 | 54 | 0.260 |
Why?
|
Indians, North American | 3 | 2014 | 352 | 0.260 |
Why?
|
Neoplasms, Multiple Primary | 1 | 2010 | 592 | 0.260 |
Why?
|
Otorhinolaryngologic Diseases | 1 | 2006 | 97 | 0.250 |
Why?
|
Tonsillar Neoplasms | 1 | 2005 | 50 | 0.250 |
Why?
|
Electrocoagulation | 1 | 2006 | 152 | 0.250 |
Why?
|
Neoplasms, Basal Cell | 2 | 2022 | 31 | 0.250 |
Why?
|
Postoperative Complications | 14 | 2021 | 15633 | 0.250 |
Why?
|
Male | 56 | 2024 | 360846 | 0.240 |
Why?
|
Middle Aged | 44 | 2024 | 220921 | 0.240 |
Why?
|
Aged | 37 | 2024 | 169310 | 0.240 |
Why?
|
Clinical Competence | 3 | 2019 | 4793 | 0.240 |
Why?
|
Heparin, Low-Molecular-Weight | 1 | 2007 | 344 | 0.240 |
Why?
|
Punctures | 5 | 2014 | 366 | 0.240 |
Why?
|
Physicians, Family | 1 | 2006 | 350 | 0.230 |
Why?
|
Adenoidectomy | 1 | 2006 | 167 | 0.230 |
Why?
|
Wound Healing | 4 | 2014 | 2805 | 0.230 |
Why?
|
Treatment Outcome | 23 | 2020 | 64685 | 0.230 |
Why?
|
Cutaneous Fistula | 3 | 2016 | 79 | 0.230 |
Why?
|
Skull | 1 | 2008 | 818 | 0.220 |
Why?
|
Graft Survival | 6 | 2018 | 3820 | 0.220 |
Why?
|
Tracheal Stenosis | 1 | 2006 | 228 | 0.220 |
Why?
|
Bone Transplantation | 1 | 2008 | 929 | 0.220 |
Why?
|
Anastomosis, Surgical | 1 | 2007 | 983 | 0.210 |
Why?
|
Venous Thrombosis | 2 | 2016 | 1303 | 0.210 |
Why?
|
Mandible | 1 | 2007 | 753 | 0.210 |
Why?
|
Paranasal Sinus Neoplasms | 2 | 2022 | 242 | 0.210 |
Why?
|
Prognosis | 12 | 2024 | 29629 | 0.200 |
Why?
|
Immunoconjugates | 1 | 2010 | 953 | 0.200 |
Why?
|
Indocyanine Green | 1 | 2023 | 233 | 0.190 |
Why?
|
Prosthesis Implantation | 3 | 2011 | 592 | 0.190 |
Why?
|
Skin Transplantation | 1 | 2007 | 1083 | 0.190 |
Why?
|
Female | 48 | 2024 | 392705 | 0.190 |
Why?
|
Antibiotic Prophylaxis | 3 | 2016 | 637 | 0.190 |
Why?
|
Adenocarcinoma, Mucinous | 1 | 2005 | 517 | 0.190 |
Why?
|
Aged, 80 and over | 14 | 2024 | 58984 | 0.190 |
Why?
|
Respiratory Syncytial Virus Infections | 1 | 2006 | 366 | 0.180 |
Why?
|
Papillomaviridae | 3 | 2022 | 1119 | 0.180 |
Why?
|
Chemoprevention | 1 | 2023 | 326 | 0.180 |
Why?
|
Trachea | 3 | 2011 | 1089 | 0.170 |
Why?
|
Speech Disorders | 1 | 2021 | 180 | 0.170 |
Why?
|
Blood Transfusion | 2 | 2018 | 1301 | 0.170 |
Why?
|
Neck Dissection | 3 | 2017 | 201 | 0.170 |
Why?
|
Antineoplastic Agents | 1 | 2023 | 13642 | 0.170 |
Why?
|
Melanosis | 1 | 2021 | 93 | 0.170 |
Why?
|
Xeroderma Pigmentosum | 1 | 2019 | 31 | 0.170 |
Why?
|
Antibodies, Viral | 2 | 2024 | 3156 | 0.170 |
Why?
|
Immunotherapy | 4 | 2023 | 4652 | 0.160 |
Why?
|
Alphapapillomavirus | 1 | 2022 | 218 | 0.160 |
Why?
|
Risk Assessment | 9 | 2021 | 23996 | 0.160 |
Why?
|
Sublingual Gland | 1 | 2018 | 11 | 0.160 |
Why?
|
Tissue and Organ Harvesting | 2 | 2019 | 373 | 0.150 |
Why?
|
Carcinoma, Acinar Cell | 1 | 2018 | 62 | 0.150 |
Why?
|
Cohort Studies | 10 | 2021 | 41495 | 0.150 |
Why?
|
Hyperplasia | 1 | 2021 | 1152 | 0.150 |
Why?
|
Neoplasms, Squamous Cell | 2 | 2021 | 95 | 0.150 |
Why?
|
Neoplasm Metastasis | 5 | 2021 | 4915 | 0.150 |
Why?
|
Melanocytes | 1 | 2021 | 509 | 0.140 |
Why?
|
Anophthalmos | 1 | 2017 | 23 | 0.140 |
Why?
|
Laryngeal Diseases | 1 | 2020 | 243 | 0.140 |
Why?
|
Tracheotomy | 1 | 2018 | 167 | 0.140 |
Why?
|
Oncolytic Virotherapy | 1 | 2023 | 516 | 0.140 |
Why?
|
Jugular Veins | 1 | 2018 | 210 | 0.140 |
Why?
|
Follow-Up Studies | 9 | 2015 | 39106 | 0.140 |
Why?
|
Models, Biological | 1 | 2013 | 9469 | 0.140 |
Why?
|
Immunosuppressive Agents | 1 | 2010 | 4176 | 0.140 |
Why?
|
Parotid Diseases | 1 | 2017 | 49 | 0.140 |
Why?
|
Internship and Residency | 4 | 2019 | 5882 | 0.140 |
Why?
|
Conjunctival Neoplasms | 1 | 2017 | 77 | 0.130 |
Why?
|
Esophagus | 3 | 2011 | 1033 | 0.130 |
Why?
|
Radiotherapy, Adjuvant | 5 | 2022 | 1784 | 0.130 |
Why?
|
Cervicoplasty | 1 | 2015 | 8 | 0.120 |
Why?
|
Tomography, X-Ray Computed | 8 | 2018 | 20568 | 0.120 |
Why?
|
Paranasal Sinuses | 2 | 2021 | 265 | 0.120 |
Why?
|
Estrogen Receptor alpha | 1 | 2019 | 583 | 0.120 |
Why?
|
Human papillomavirus 16 | 1 | 2017 | 267 | 0.120 |
Why?
|
Deglutition Disorders | 1 | 2021 | 625 | 0.120 |
Why?
|
Urinary Tract Infections | 1 | 2021 | 802 | 0.120 |
Why?
|
Tongue Neoplasms | 1 | 2017 | 183 | 0.120 |
Why?
|
Actinomycosis | 1 | 2014 | 19 | 0.120 |
Why?
|
Clostridium Infections | 1 | 2021 | 558 | 0.120 |
Why?
|
Hospitals, University | 1 | 2016 | 564 | 0.120 |
Why?
|
Bacteremia | 1 | 2021 | 980 | 0.120 |
Why?
|
Combined Modality Therapy | 6 | 2016 | 8527 | 0.120 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 1 | 2020 | 1092 | 0.120 |
Why?
|
Arthritis, Rheumatoid | 1 | 2010 | 3763 | 0.120 |
Why?
|
Mastoid | 1 | 2014 | 100 | 0.110 |
Why?
|
Pharyngeal Neoplasms | 1 | 2014 | 113 | 0.110 |
Why?
|
Area Under Curve | 1 | 2018 | 1638 | 0.110 |
Why?
|
Pharynx | 1 | 2017 | 432 | 0.110 |
Why?
|
Ear Neoplasms | 1 | 2014 | 118 | 0.110 |
Why?
|
Frozen Sections | 1 | 2014 | 153 | 0.110 |
Why?
|
Postoperative Hemorrhage | 2 | 2015 | 415 | 0.110 |
Why?
|
Head | 1 | 2019 | 924 | 0.110 |
Why?
|
Conjunctiva | 1 | 2017 | 479 | 0.110 |
Why?
|
Schwann Cells | 1 | 2014 | 197 | 0.110 |
Why?
|
Length of Stay | 6 | 2021 | 6426 | 0.110 |
Why?
|
Ligands | 1 | 2020 | 3272 | 0.110 |
Why?
|
Salvage Therapy | 2 | 2011 | 1263 | 0.110 |
Why?
|
Antiviral Agents | 1 | 2006 | 3060 | 0.110 |
Why?
|
Adult | 18 | 2021 | 221210 | 0.110 |
Why?
|
Magnetic Resonance Imaging | 7 | 2021 | 36426 | 0.100 |
Why?
|
Confidence Intervals | 1 | 2018 | 2927 | 0.100 |
Why?
|
Shoulder | 1 | 2014 | 300 | 0.100 |
Why?
|
Nerve Tissue | 1 | 2012 | 78 | 0.100 |
Why?
|
Needs Assessment | 1 | 2018 | 1139 | 0.100 |
Why?
|
Pilot Projects | 4 | 2021 | 8633 | 0.100 |
Why?
|
Infratentorial Neoplasms | 1 | 2012 | 98 | 0.100 |
Why?
|
Bibliometrics | 1 | 2015 | 352 | 0.100 |
Why?
|
Sensitivity and Specificity | 2 | 2018 | 14665 | 0.090 |
Why?
|
Cranial Nerve Neoplasms | 1 | 2012 | 134 | 0.090 |
Why?
|
SEER Program | 2 | 2013 | 1450 | 0.090 |
Why?
|
Hypopharyngeal Neoplasms | 1 | 2011 | 51 | 0.090 |
Why?
|
Treatment Refusal | 1 | 2014 | 429 | 0.090 |
Why?
|
Nerve Sheath Neoplasms | 1 | 2012 | 170 | 0.090 |
Why?
|
Cell Cycle Proteins | 1 | 2022 | 3449 | 0.090 |
Why?
|
Salivary Gland Neoplasms | 1 | 2014 | 304 | 0.090 |
Why?
|
Pain, Postoperative | 1 | 2021 | 1740 | 0.090 |
Why?
|
ROC Curve | 1 | 2018 | 3578 | 0.090 |
Why?
|
Oropharynx | 1 | 2011 | 138 | 0.090 |
Why?
|
Neuroma, Acoustic | 1 | 2014 | 459 | 0.090 |
Why?
|
Survival Rate | 4 | 2018 | 12723 | 0.090 |
Why?
|
Human papillomavirus 11 | 1 | 2009 | 14 | 0.080 |
Why?
|
Diagnosis, Differential | 5 | 2012 | 12973 | 0.080 |
Why?
|
Pneumonia | 1 | 2021 | 2143 | 0.080 |
Why?
|
Respiratory Tract Neoplasms | 1 | 2009 | 56 | 0.080 |
Why?
|
Graft Rejection | 3 | 2018 | 4446 | 0.080 |
Why?
|
Preoperative Care | 1 | 2018 | 2242 | 0.080 |
Why?
|
Speech, Alaryngeal | 1 | 2009 | 32 | 0.080 |
Why?
|
Skin | 1 | 2023 | 4484 | 0.080 |
Why?
|
Medical Oncology | 1 | 2021 | 2321 | 0.080 |
Why?
|
Young Adult | 8 | 2021 | 59260 | 0.080 |
Why?
|
Antibodies, Monoclonal | 1 | 2006 | 9177 | 0.080 |
Why?
|
Speech Intelligibility | 1 | 2009 | 79 | 0.080 |
Why?
|
Papilloma | 1 | 2009 | 140 | 0.080 |
Why?
|
Reproducibility of Results | 2 | 2018 | 20100 | 0.080 |
Why?
|
Biopsy | 2 | 2010 | 6766 | 0.080 |
Why?
|
Publishing | 1 | 2015 | 833 | 0.070 |
Why?
|
Pharyngeal Diseases | 1 | 2009 | 134 | 0.070 |
Why?
|
Nuclear Proteins | 1 | 2022 | 5799 | 0.070 |
Why?
|
Occlusive Dressings | 1 | 2007 | 52 | 0.070 |
Why?
|
Fistula | 1 | 2009 | 212 | 0.070 |
Why?
|
Massachusetts | 5 | 2021 | 8833 | 0.070 |
Why?
|
Gene Expression | 1 | 2019 | 7581 | 0.070 |
Why?
|
Splints | 1 | 2007 | 108 | 0.070 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2020 | 4580 | 0.070 |
Why?
|
Apoptosis | 2 | 2020 | 9490 | 0.070 |
Why?
|
Risk Factors | 10 | 2020 | 74213 | 0.070 |
Why?
|
Clinical Trials, Phase IV as Topic | 1 | 2006 | 29 | 0.070 |
Why?
|
Immunohistochemistry | 3 | 2019 | 11076 | 0.060 |
Why?
|
Bone Neoplasms | 1 | 2017 | 2529 | 0.060 |
Why?
|
Hematocrit | 2 | 2018 | 623 | 0.060 |
Why?
|
Osteogenesis, Distraction | 1 | 2007 | 227 | 0.060 |
Why?
|
United States | 8 | 2022 | 72340 | 0.060 |
Why?
|
Kaplan-Meier Estimate | 2 | 2013 | 6484 | 0.060 |
Why?
|
South Dakota | 2 | 2014 | 32 | 0.060 |
Why?
|
Analgesics, Opioid | 1 | 2021 | 3808 | 0.060 |
Why?
|
Hypertrophy | 1 | 2006 | 561 | 0.060 |
Why?
|
Neoplasms | 2 | 2023 | 22173 | 0.060 |
Why?
|
Survival Analysis | 2 | 2014 | 10090 | 0.060 |
Why?
|
Epithelial-Mesenchymal Transition | 2 | 2019 | 738 | 0.060 |
Why?
|
Neoplasm Recurrence, Local | 4 | 2021 | 9280 | 0.060 |
Why?
|
Bacteria | 1 | 2014 | 2199 | 0.060 |
Why?
|
Adaptation, Psychological | 1 | 2014 | 2629 | 0.050 |
Why?
|
Patient Readmission | 1 | 2017 | 3271 | 0.050 |
Why?
|
Carcinoma | 1 | 2014 | 2330 | 0.050 |
Why?
|
Adolescent | 6 | 2019 | 88326 | 0.050 |
Why?
|
Pharyngectomy | 2 | 2014 | 44 | 0.050 |
Why?
|
Methicillin-Resistant Staphylococcus aureus | 2 | 2021 | 698 | 0.050 |
Why?
|
Fatal Outcome | 2 | 2021 | 1835 | 0.050 |
Why?
|
Transcription Factors | 1 | 2022 | 12130 | 0.050 |
Why?
|
Random Allocation | 1 | 2007 | 2395 | 0.050 |
Why?
|
Polyomavirus Infections | 1 | 2024 | 194 | 0.050 |
Why?
|
Microcirculation | 1 | 2007 | 1272 | 0.050 |
Why?
|
Students, Medical | 1 | 2014 | 1936 | 0.050 |
Why?
|
Tumor Virus Infections | 1 | 2024 | 438 | 0.050 |
Why?
|
Fluorescence | 1 | 2023 | 756 | 0.050 |
Why?
|
Internet | 1 | 2013 | 3093 | 0.050 |
Why?
|
Physician-Patient Relations | 1 | 2014 | 3251 | 0.050 |
Why?
|
Prospective Studies | 4 | 2021 | 54423 | 0.050 |
Why?
|
Tumor Burden | 2 | 2021 | 1892 | 0.050 |
Why?
|
Interdisciplinary Studies | 1 | 2021 | 86 | 0.040 |
Why?
|
Multicenter Studies as Topic | 1 | 2006 | 1702 | 0.040 |
Why?
|
Chi-Square Distribution | 1 | 2007 | 3415 | 0.040 |
Why?
|
Flow Cytometry | 1 | 2010 | 5870 | 0.040 |
Why?
|
Radius | 1 | 2023 | 441 | 0.040 |
Why?
|
Disease Progression | 4 | 2021 | 13510 | 0.040 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2014 | 4016 | 0.040 |
Why?
|
Deglutition | 1 | 2021 | 208 | 0.040 |
Why?
|
Biomedical Research | 1 | 2015 | 3429 | 0.040 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2009 | 2827 | 0.040 |
Why?
|
Palate, Soft | 1 | 2019 | 100 | 0.040 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2016 | 9001 | 0.040 |
Why?
|
Nasal Mucosa | 1 | 2022 | 416 | 0.040 |
Why?
|
Mass Screening | 1 | 2014 | 5429 | 0.040 |
Why?
|
Catheter-Related Infections | 1 | 2021 | 273 | 0.040 |
Why?
|
Professional Autonomy | 1 | 2019 | 171 | 0.040 |
Why?
|
Predictive Value of Tests | 1 | 2014 | 15266 | 0.040 |
Why?
|
Patient Discharge | 2 | 2021 | 3443 | 0.040 |
Why?
|
Dissection | 1 | 2019 | 298 | 0.040 |
Why?
|
Mucous Membrane | 1 | 2021 | 659 | 0.040 |
Why?
|
Tissue Engineering | 1 | 2007 | 1868 | 0.040 |
Why?
|
Nasal Cavity | 1 | 2019 | 304 | 0.040 |
Why?
|
Ultraviolet Rays | 1 | 2022 | 1080 | 0.040 |
Why?
|
Oncogenes | 1 | 2022 | 1222 | 0.030 |
Why?
|
Clindamycin | 1 | 2016 | 139 | 0.030 |
Why?
|
Speech | 1 | 2021 | 554 | 0.030 |
Why?
|
Anti-Bacterial Agents | 2 | 2016 | 7406 | 0.030 |
Why?
|
Workflow | 1 | 2021 | 851 | 0.030 |
Why?
|
Nose | 1 | 2019 | 521 | 0.030 |
Why?
|
Rats, Sprague-Dawley | 1 | 2007 | 8181 | 0.030 |
Why?
|
Fluorescent Dyes | 1 | 2023 | 1903 | 0.030 |
Why?
|
Reoperation | 1 | 2006 | 4303 | 0.030 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2022 | 11742 | 0.030 |
Why?
|
Neoadjuvant Therapy | 2 | 2021 | 2828 | 0.030 |
Why?
|
Cadaver | 1 | 2019 | 1358 | 0.030 |
Why?
|
Incidence | 4 | 2015 | 21355 | 0.030 |
Why?
|
Neck | 1 | 2019 | 734 | 0.030 |
Why?
|
DNA, Viral | 1 | 2022 | 2202 | 0.030 |
Why?
|
Sequence Analysis, RNA | 1 | 2022 | 2021 | 0.030 |
Why?
|
Quality of Life | 4 | 2021 | 13367 | 0.030 |
Why?
|
Positron-Emission Tomography | 1 | 2010 | 6484 | 0.030 |
Why?
|
Drug Approval | 1 | 2021 | 814 | 0.030 |
Why?
|
Comorbidity | 1 | 2009 | 10508 | 0.030 |
Why?
|
Kinetics | 1 | 2022 | 6374 | 0.030 |
Why?
|
Cleft Palate | 1 | 2019 | 589 | 0.030 |
Why?
|
Infant | 2 | 2006 | 36193 | 0.030 |
Why?
|
Child | 2 | 2016 | 80158 | 0.030 |
Why?
|
Postoperative Period | 1 | 2018 | 1814 | 0.030 |
Why?
|
Time Factors | 3 | 2014 | 39969 | 0.030 |
Why?
|
Recurrence | 1 | 2006 | 8466 | 0.030 |
Why?
|
United States Food and Drug Administration | 1 | 2021 | 1664 | 0.030 |
Why?
|
Immunologic Factors | 1 | 2022 | 1590 | 0.030 |
Why?
|
Child, Preschool | 2 | 2006 | 42232 | 0.030 |
Why?
|
Oncogene Proteins, Fusion | 1 | 2021 | 1609 | 0.030 |
Why?
|
Consensus | 1 | 2022 | 3124 | 0.030 |
Why?
|
Alaska | 1 | 2012 | 70 | 0.030 |
Why?
|
Esthetics | 1 | 2014 | 330 | 0.020 |
Why?
|
Cranial Nerve Diseases | 1 | 2012 | 113 | 0.020 |
Why?
|
Skull Neoplasms | 1 | 2012 | 173 | 0.020 |
Why?
|
Brain | 2 | 2021 | 27121 | 0.020 |
Why?
|
Paralysis | 1 | 2012 | 250 | 0.020 |
Why?
|
Forecasting | 1 | 2020 | 2928 | 0.020 |
Why?
|
Rats | 1 | 2007 | 23741 | 0.020 |
Why?
|
Chromatin | 1 | 2022 | 2961 | 0.020 |
Why?
|
Cells, Cultured | 2 | 2017 | 18966 | 0.020 |
Why?
|
Disease-Free Survival | 2 | 2011 | 6815 | 0.020 |
Why?
|
Opportunistic Infections | 1 | 2012 | 376 | 0.020 |
Why?
|
Workload | 1 | 2015 | 844 | 0.020 |
Why?
|
Practice Guidelines as Topic | 1 | 2006 | 7391 | 0.020 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2021 | 3639 | 0.020 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2006 | 10212 | 0.020 |
Why?
|
Focus Groups | 1 | 2014 | 1415 | 0.020 |
Why?
|
Proteomics | 1 | 2022 | 3848 | 0.020 |
Why?
|
Career Choice | 1 | 2014 | 756 | 0.020 |
Why?
|
Cross-Sectional Studies | 2 | 2019 | 26129 | 0.020 |
Why?
|
Academic Medical Centers | 1 | 2018 | 2759 | 0.020 |
Why?
|
Educational Status | 1 | 2015 | 2522 | 0.020 |
Why?
|
Staphylococcal Infections | 1 | 2016 | 1407 | 0.020 |
Why?
|
Clinical Trials, Phase II as Topic | 1 | 2009 | 629 | 0.020 |
Why?
|
Societies, Medical | 1 | 2018 | 3905 | 0.020 |
Why?
|
Single-Cell Analysis | 1 | 2017 | 2451 | 0.020 |
Why?
|
Carboplatin | 1 | 2009 | 794 | 0.020 |
Why?
|
Organ Preservation | 1 | 2009 | 382 | 0.020 |
Why?
|
Cartilage | 1 | 2009 | 806 | 0.020 |
Why?
|
Cell Line, Tumor | 1 | 2022 | 16990 | 0.020 |
Why?
|
Quality Assurance, Health Care | 1 | 2015 | 2169 | 0.020 |
Why?
|
Guideline Adherence | 1 | 2015 | 2220 | 0.020 |
Why?
|
Multivariate Analysis | 1 | 2018 | 12059 | 0.020 |
Why?
|
Proportional Hazards Models | 1 | 2019 | 12463 | 0.010 |
Why?
|
Enteral Nutrition | 1 | 2011 | 794 | 0.010 |
Why?
|
Tumor Microenvironment | 1 | 2017 | 3878 | 0.010 |
Why?
|
Fluorouracil | 1 | 2009 | 1642 | 0.010 |
Why?
|
Quality Improvement | 1 | 2019 | 3802 | 0.010 |
Why?
|
Probability | 1 | 2009 | 2477 | 0.010 |
Why?
|
Prosthesis Failure | 1 | 2009 | 1204 | 0.010 |
Why?
|
Logistic Models | 1 | 2018 | 13255 | 0.010 |
Why?
|
Statistics, Nonparametric | 1 | 2009 | 2850 | 0.010 |
Why?
|
Remission Induction | 1 | 2009 | 2397 | 0.010 |
Why?
|
Cisplatin | 1 | 2009 | 1652 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2020 | 22176 | 0.010 |
Why?
|
Prosthesis Design | 1 | 2009 | 2115 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2017 | 9420 | 0.010 |
Why?
|
Health Status Disparities | 1 | 2012 | 1853 | 0.010 |
Why?
|
Socioeconomic Factors | 1 | 2014 | 7828 | 0.010 |
Why?
|
Feasibility Studies | 1 | 2011 | 5247 | 0.010 |
Why?
|
Contrast Media | 1 | 2012 | 5307 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2014 | 10451 | 0.010 |
Why?
|
Radiography | 1 | 2009 | 6965 | 0.010 |
Why?
|
Pain | 1 | 2012 | 5073 | 0.010 |
Why?
|
Signal Transduction | 1 | 2019 | 23447 | 0.010 |
Why?
|
Animals | 1 | 2007 | 168475 | 0.010 |
Why?
|